ANZALONE CHRISTOPHER RICHARD

PrivateCIK: 1423029
Location

PASADENA, CA

ANZALONE CHRISTOPHER RICHARD (Chief Executive Officer) sold 1.3% of their position (51.73K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $3.58M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-51.73K
Net shares
Net seller
$3.58M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
51.73K acquired · 103.45K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+35.18K

Price / share

$6.15

Trade value

$216.36K

% of position

0.9%
12/29/2025
3.81M→3.84M

Common Stock

Direct
M · Option Exercise

Shares

+16.55K

Price / share

$6.15

Trade value

$101.75K

% of position

0.4%
12/29/2025
3.84M→3.86M

Common Stock

Direct
S · Sale

Shares

−35.18K

Price / share

$69.33

Trade value

$2.44M

% of position

0.9%
12/29/2025
3.86M→3.82M

Common Stock

Direct
S · Sale

Shares

−16.55K

Price / share

$68.69

Trade value

$1.14M

% of position

0.4%
12/29/2025
3.82M→3.81M
Total

Net shares

+0.00

Net value

-$3.26M

Derivative Transactions2

Stock Option (right to buy Common Stock)

Direct
M · Option Exercise
Converts to

Common Stock

35.18K shares

Shares

−35.18K

Strike price

6.15

Held after

16.55K

Exercisable

—

12/29/2025

Stock Option (right to buy Common Stock)

Direct
M · Option Exercise
Converts to

Common Stock

16.55K shares

Shares

−16.55K

Strike price

6.15

Held after

0.00

Exercisable

—

12/29/2025
ANZALONE CHRISTOPHER RICHARD — Insider Transaction (Form 4) Filed Dec 30, 2025 | Finecho